« Back to Record
Wirth, M. M., Heidenreich, A., Gschwend, J. J., Gil, T., Zastrow, S., Laniado, M., Gerloff, J., Zühlsdorf, M., Mordenti, G., Uhl, W., & Lannert, H. (2014). A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy. European urology, 65(5), 897-904. doi:10.1016/j.eururo.2013.05.051
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168906



